Episode 100: 2023 ECTRIMS-ACTRIMS Meeting Highlights

Author(s):

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Mitzi Joi Williams, MD; Rhonda Voskuhl, MD, PhD; Tom Fuchs, MD, PhD; Barry Singer, MD; and Georgina Arrambide, MD, PhD. [LISTEN TIME: 15 minutes]

Episode 100 of the NeurologyLive^® Mind Moments^® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Episode 100, "2023 ECTRIMS-ACTRIMS Meeting Highlights" features an interview with from a variety of specialists in neurology who presented research and gave talks at the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy. Those included in this week's episode, in order of appearance, are:

Mitzi Joi Williams, MD, founder and chief executive officer of the Joi Life Wellness Group Multiple Sclerosis Center.
Rhonda Voskuhl, the director of the Multiple Sclerosis Program at UCLA.
Tom Fuchs, MD, PhD, a research fellow at the MS Center at Amsterdam University Medical Center.
Barry Singer, MD, the director and founder of The MS Center for Innovations in Care.
Georgina Arrambide, a clinical neurologist in the MS Center of Catalunya.

This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences^®. Check out new content and shows every day, only at medicalworldnews.com

EPISODE BREAKDOWN

1:10 – Joi Williams on expanding the use of biomarkers and the next steps in advancing precision medicine for multiple sclerosis treatment.
2:20 – Voskuhl on the increased research efforts to better understand the links between aging, menopause, and women with MS.
4:30 – Fuchs on the challenges of tracking cognitive decline in multiple sclerosis and improving currently available assessments.
7:50 – Singer on the introduction of biosimilars to MS care, the rigorous approval process they undergo, and the potential benefits they bring to the field.
11:45 – Arrambide on an updated consensus approach to the differential diagnosis of suspected multiple sclerosis, and the red flags clinicians should be aware of during this process.

Click here to subscribe to the Mind Moments podcast. Be sure to leave a rating and review for the show. Thanks for listening!

Hoping to listen on your favorite podcast app? See below: